Oral GLP-1 receptor agonists: competition for efficacy and tolerability

The Lancet 2026

View at publisher

Authors: Michael Albrecht Nauck, Michael Horowitz

DOI: 10.1016/s0140-6736(26)00360-0

Cited by: 0

References: 12

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Pharmacology and Obesity Treatment

References 12